ID   SPTC1_RAT               Reviewed;         473 AA.
AC   D4A2H2;
DT   13-FEB-2019, integrated into UniProtKB/Swiss-Prot.
DT   20-APR-2010, sequence version 1.
DT   02-OCT-2024, entry version 93.
DE   RecName: Full=Serine palmitoyltransferase 1 {ECO:0000305};
DE            EC=2.3.1.50 {ECO:0000250|UniProtKB:O15269};
DE   AltName: Full=Long chain base biosynthesis protein 1;
DE            Short=LCB 1;
DE   AltName: Full=Serine-palmitoyl-CoA transferase 1;
DE            Short=SPT 1;
DE            Short=SPT1;
GN   Name=Sptlc1 {ECO:0000312|RGD:1307140}; Synonyms=Lcb1; ORFNames=rCG_44191;
OS   Rattus norvegicus (Rat).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia;
OC   Eutheria; Euarchontoglires; Glires; Rodentia; Myomorpha; Muroidea; Muridae;
OC   Murinae; Rattus.
OX   NCBI_TaxID=10116;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RC   STRAIN=Brown Norway;
RX   PubMed=15057822; DOI=10.1038/nature02426;
RA   Gibbs R.A., Weinstock G.M., Metzker M.L., Muzny D.M., Sodergren E.J.,
RA   Scherer S., Scott G., Steffen D., Worley K.C., Burch P.E., Okwuonu G.,
RA   Hines S., Lewis L., Deramo C., Delgado O., Dugan-Rocha S., Miner G.,
RA   Morgan M., Hawes A., Gill R., Holt R.A., Adams M.D., Amanatides P.G.,
RA   Baden-Tillson H., Barnstead M., Chin S., Evans C.A., Ferriera S.,
RA   Fosler C., Glodek A., Gu Z., Jennings D., Kraft C.L., Nguyen T.,
RA   Pfannkoch C.M., Sitter C., Sutton G.G., Venter J.C., Woodage T., Smith D.,
RA   Lee H.-M., Gustafson E., Cahill P., Kana A., Doucette-Stamm L.,
RA   Weinstock K., Fechtel K., Weiss R.B., Dunn D.M., Green E.D.,
RA   Blakesley R.W., Bouffard G.G., De Jong P.J., Osoegawa K., Zhu B., Marra M.,
RA   Schein J., Bosdet I., Fjell C., Jones S., Krzywinski M., Mathewson C.,
RA   Siddiqui A., Wye N., McPherson J., Zhao S., Fraser C.M., Shetty J.,
RA   Shatsman S., Geer K., Chen Y., Abramzon S., Nierman W.C., Havlak P.H.,
RA   Chen R., Durbin K.J., Egan A., Ren Y., Song X.-Z., Li B., Liu Y., Qin X.,
RA   Cawley S., Cooney A.J., D'Souza L.M., Martin K., Wu J.Q.,
RA   Gonzalez-Garay M.L., Jackson A.R., Kalafus K.J., McLeod M.P.,
RA   Milosavljevic A., Virk D., Volkov A., Wheeler D.A., Zhang Z., Bailey J.A.,
RA   Eichler E.E., Tuzun E., Birney E., Mongin E., Ureta-Vidal A., Woodwark C.,
RA   Zdobnov E., Bork P., Suyama M., Torrents D., Alexandersson M., Trask B.J.,
RA   Young J.M., Huang H., Wang H., Xing H., Daniels S., Gietzen D., Schmidt J.,
RA   Stevens K., Vitt U., Wingrove J., Camara F., Mar Alba M., Abril J.F.,
RA   Guigo R., Smit A., Dubchak I., Rubin E.M., Couronne O., Poliakov A.,
RA   Huebner N., Ganten D., Goesele C., Hummel O., Kreitler T., Lee Y.-A.,
RA   Monti J., Schulz H., Zimdahl H., Himmelbauer H., Lehrach H., Jacob H.J.,
RA   Bromberg S., Gullings-Handley J., Jensen-Seaman M.I., Kwitek A.E.,
RA   Lazar J., Pasko D., Tonellato P.J., Twigger S., Ponting C.P., Duarte J.M.,
RA   Rice S., Goodstadt L., Beatson S.A., Emes R.D., Winter E.E., Webber C.,
RA   Brandt P., Nyakatura G., Adetobi M., Chiaromonte F., Elnitski L.,
RA   Eswara P., Hardison R.C., Hou M., Kolbe D., Makova K., Miller W.,
RA   Nekrutenko A., Riemer C., Schwartz S., Taylor J., Yang S., Zhang Y.,
RA   Lindpaintner K., Andrews T.D., Caccamo M., Clamp M., Clarke L., Curwen V.,
RA   Durbin R.M., Eyras E., Searle S.M., Cooper G.M., Batzoglou S., Brudno M.,
RA   Sidow A., Stone E.A., Payseur B.A., Bourque G., Lopez-Otin C., Puente X.S.,
RA   Chakrabarti K., Chatterji S., Dewey C., Pachter L., Bray N., Yap V.B.,
RA   Caspi A., Tesler G., Pevzner P.A., Haussler D., Roskin K.M., Baertsch R.,
RA   Clawson H., Furey T.S., Hinrichs A.S., Karolchik D., Kent W.J.,
RA   Rosenbloom K.R., Trumbower H., Weirauch M., Cooper D.N., Stenson P.D.,
RA   Ma B., Brent M., Arumugam M., Shteynberg D., Copley R.R., Taylor M.S.,
RA   Riethman H., Mudunuri U., Peterson J., Guyer M., Felsenfeld A., Old S.,
RA   Mockrin S., Collins F.S.;
RT   "Genome sequence of the Brown Norway rat yields insights into mammalian
RT   evolution.";
RL   Nature 428:493-521(2004).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RA   Mural R.J., Adams M.D., Myers E.W., Smith H.O., Venter J.C.;
RL   Submitted (JUL-2005) to the EMBL/GenBank/DDBJ databases.
RN   [3]
RP   INDUCTION BY MIRNA, AND TISSUE SPECIFICITY.
RX   PubMed=21994399; DOI=10.1523/jneurosci.3883-11.2011;
RA   Geekiyanage H., Chan C.;
RT   "MicroRNA-137/181c regulates serine palmitoyltransferase and in turn
RT   amyloid beta, novel targets in sporadic Alzheimer's disease.";
RL   J. Neurosci. 31:14820-14830(2011).
CC   -!- FUNCTION: Component of the serine palmitoyltransferase multisubunit
CC       enzyme (SPT) that catalyzes the initial and rate-limiting step in
CC       sphingolipid biosynthesis by condensing L-serine and activated acyl-CoA
CC       (most commonly palmitoyl-CoA) to form long-chain bases. The SPT complex
CC       is also composed of SPTLC2 or SPTLC3 and SPTSSA or SPTSSB. Within this
CC       complex, the heterodimer with SPTLC2 or SPTLC3 forms the catalytic
CC       core. The composition of the serine palmitoyltransferase (SPT) complex
CC       determines the substrate preference. The SPTLC1-SPTLC2-SPTSSA complex
CC       shows a strong preference for C16-CoA substrate, while the SPTLC1-
CC       SPTLC3-SPTSSA isozyme uses both C14-CoA and C16-CoA as substrates, with
CC       a slight preference for C14-CoA. The SPTLC1-SPTLC2-SPTSSB complex shows
CC       a strong preference for C18-CoA substrate, while the SPTLC1-SPTLC3-
CC       SPTSSB isozyme displays an ability to use a broader range of acyl-CoAs,
CC       without apparent preference (By similarity). Required for adipocyte
CC       cell viability and metabolic homeostasis (By similarity).
CC       {ECO:0000250|UniProtKB:O15269, ECO:0000250|UniProtKB:O35704}.
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=H(+) + hexadecanoyl-CoA + L-serine = 3-oxosphinganine + CO2 +
CC         CoA; Xref=Rhea:RHEA:14761, ChEBI:CHEBI:15378, ChEBI:CHEBI:16526,
CC         ChEBI:CHEBI:33384, ChEBI:CHEBI:57287, ChEBI:CHEBI:57379,
CC         ChEBI:CHEBI:58299; EC=2.3.1.50;
CC         Evidence={ECO:0000250|UniProtKB:O15269};
CC       PhysiologicalDirection=left-to-right; Xref=Rhea:RHEA:14762;
CC         Evidence={ECO:0000250|UniProtKB:O15269};
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=H(+) + L-serine + octadecanoyl-CoA = 3-oxoeicosasphinganine +
CC         CO2 + CoA; Xref=Rhea:RHEA:33683, ChEBI:CHEBI:15378,
CC         ChEBI:CHEBI:16526, ChEBI:CHEBI:33384, ChEBI:CHEBI:57287,
CC         ChEBI:CHEBI:57394, ChEBI:CHEBI:65073;
CC         Evidence={ECO:0000250|UniProtKB:O15269};
CC       PhysiologicalDirection=left-to-right; Xref=Rhea:RHEA:33684;
CC         Evidence={ECO:0000250|UniProtKB:O15269};
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=H(+) + L-serine + tetradecanoyl-CoA = 3-oxohexadecasphinganine
CC         + CO2 + CoA; Xref=Rhea:RHEA:35675, ChEBI:CHEBI:15378,
CC         ChEBI:CHEBI:16526, ChEBI:CHEBI:33384, ChEBI:CHEBI:57287,
CC         ChEBI:CHEBI:57385, ChEBI:CHEBI:71007;
CC         Evidence={ECO:0000250|UniProtKB:O15269};
CC       PhysiologicalDirection=left-to-right; Xref=Rhea:RHEA:35676;
CC         Evidence={ECO:0000250|UniProtKB:O15269};
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=dodecanoyl-CoA + H(+) + L-serine = 3-oxotetradecasphinganine +
CC         CO2 + CoA; Xref=Rhea:RHEA:35679, ChEBI:CHEBI:15378,
CC         ChEBI:CHEBI:16526, ChEBI:CHEBI:33384, ChEBI:CHEBI:57287,
CC         ChEBI:CHEBI:57375, ChEBI:CHEBI:71008;
CC         Evidence={ECO:0000250|UniProtKB:O15269};
CC       PhysiologicalDirection=left-to-right; Xref=Rhea:RHEA:35680;
CC         Evidence={ECO:0000250|UniProtKB:O15269};
CC   -!- COFACTOR:
CC       Name=pyridoxal 5'-phosphate; Xref=ChEBI:CHEBI:597326;
CC         Evidence={ECO:0000250};
CC   -!- ACTIVITY REGULATION: SPT complex catalytic activity is negatively
CC       regulated by ORMDL proteins, including ORMDL3, in the presence of
CC       ceramides (By similarity). This mechanism allows to maintain ceramide
CC       levels at sufficient concentrations for the production of complex
CC       sphingolipids, but which prevents the accumulation of ceramides to
CC       levels that trigger apoptosis (Probable).
CC       {ECO:0000250|UniProtKB:O15269, ECO:0000305}.
CC   -!- PATHWAY: Lipid metabolism; sphingolipid metabolism.
CC       {ECO:0000250|UniProtKB:O15269}.
CC   -!- SUBUNIT: Component of the serine palmitoyltransferase (SPT) complex,
CC       which is also composed of SPTLC2 or SPTLC3 and SPTSSA or SPTSSB (By
CC       similarity). The heterodimer with SPTLC2 or SPTLC3 forms the catalytic
CC       core of the enzyme, while SPTSSA or SPTSSB subunits determine substrate
CC       specificity (By similarity). SPT also interacts with ORMDL proteins,
CC       especially ORMDL3, which negatively regulate SPT activity in the
CC       presence of ceramides (By similarity). Forms dimers of heterodimers
CC       with SPTLC2 (By similarity). Interacts with RTN4 (isoform B) (By
CC       similarity). {ECO:0000250|UniProtKB:O15269,
CC       ECO:0000250|UniProtKB:O35704}.
CC   -!- SUBCELLULAR LOCATION: Endoplasmic reticulum membrane
CC       {ECO:0000250|UniProtKB:O35704}; Single-pass membrane protein
CC       {ECO:0000250|UniProtKB:O35704}.
CC   -!- TISSUE SPECIFICITY: Expressed in astrocytes.
CC       {ECO:0000269|PubMed:21994399}.
CC   -!- INDUCTION: Expression in increased by palmitate at the protein level,
CC       but not at the mRNA level (PubMed:21994399). Expression is down-
CC       regulated by microRNA miR-137 and miR-181c (at protein level)
CC       (PubMed:21994399). {ECO:0000269|PubMed:21994399}.
CC   -!- DOMAIN: The transmembrane domain is involved in the interaction with
CC       ORMDL3. {ECO:0000250|UniProtKB:O15269}.
CC   -!- PTM: Phosphorylation at Tyr-164 inhibits activity and promotes cell
CC       survival. {ECO:0000250|UniProtKB:O15269}.
CC   -!- SIMILARITY: Belongs to the class-II pyridoxal-phosphate-dependent
CC       aminotransferase family. {ECO:0000305}.
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; AABR07027039; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; CH473977; EDL98057.1; -; Genomic_DNA.
DR   RefSeq; NP_001101876.1; NM_001108406.1.
DR   AlphaFoldDB; D4A2H2; -.
DR   SMR; D4A2H2; -.
DR   STRING; 10116.ENSRNOP00000014546; -.
DR   PhosphoSitePlus; D4A2H2; -.
DR   jPOST; D4A2H2; -.
DR   PaxDb; 10116-ENSRNOP00000014546; -.
DR   PeptideAtlas; D4A2H2; -.
DR   Ensembl; ENSRNOT00000014546.5; ENSRNOP00000014546.4; ENSRNOG00000010882.5.
DR   Ensembl; ENSRNOT00055023554; ENSRNOP00055019163; ENSRNOG00055013703.
DR   Ensembl; ENSRNOT00060030711; ENSRNOP00060024860; ENSRNOG00060017891.
DR   Ensembl; ENSRNOT00065016296; ENSRNOP00065012356; ENSRNOG00065010108.
DR   GeneID; 361213; -.
DR   KEGG; rno:361213; -.
DR   AGR; RGD:1307140; -.
DR   CTD; 10558; -.
DR   RGD; 1307140; Sptlc1.
DR   eggNOG; KOG1358; Eukaryota.
DR   GeneTree; ENSGT00550000074872; -.
DR   HOGENOM; CLU_015846_0_1_1; -.
DR   InParanoid; D4A2H2; -.
DR   OMA; LTKYGCG; -.
DR   OrthoDB; 9643at2759; -.
DR   PhylomeDB; D4A2H2; -.
DR   TreeFam; TF314877; -.
DR   BRENDA; 2.3.1.50; 5301.
DR   Reactome; R-RNO-1660661; Sphingolipid de novo biosynthesis.
DR   UniPathway; UPA00222; -.
DR   PRO; PR:D4A2H2; -.
DR   Proteomes; UP000002494; Chromosome 17.
DR   Proteomes; UP000234681; Chromosome 17.
DR   Bgee; ENSRNOG00000010882; Expressed in ovary and 20 other cell types or tissues.
DR   GO; GO:0005783; C:endoplasmic reticulum; IBA:GO_Central.
DR   GO; GO:0005789; C:endoplasmic reticulum membrane; ISO:RGD.
DR   GO; GO:0017059; C:serine palmitoyltransferase complex; ISO:RGD.
DR   GO; GO:0030170; F:pyridoxal phosphate binding; IEA:InterPro.
DR   GO; GO:0004758; F:serine C-palmitoyltransferase activity; ISO:RGD.
DR   GO; GO:0046513; P:ceramide biosynthetic process; ISO:RGD.
DR   GO; GO:1904504; P:positive regulation of lipophagy; ISO:RGD.
DR   GO; GO:1904649; P:regulation of fat cell apoptotic process; ISO:RGD.
DR   GO; GO:0046511; P:sphinganine biosynthetic process; ISO:RGD.
DR   GO; GO:0030148; P:sphingolipid biosynthetic process; ISO:RGD.
DR   GO; GO:0006665; P:sphingolipid metabolic process; ISO:RGD.
DR   GO; GO:0006686; P:sphingomyelin biosynthetic process; ISO:RGD.
DR   GO; GO:0046512; P:sphingosine biosynthetic process; ISO:RGD.
DR   Gene3D; 3.90.1150.10; Aspartate Aminotransferase, domain 1; 1.
DR   Gene3D; 3.40.640.10; Type I PLP-dependent aspartate aminotransferase-like (Major domain); 1.
DR   InterPro; IPR004839; Aminotransferase_I/II.
DR   InterPro; IPR050087; AON_synthase_class-II.
DR   InterPro; IPR015424; PyrdxlP-dep_Trfase.
DR   InterPro; IPR015421; PyrdxlP-dep_Trfase_major.
DR   InterPro; IPR015422; PyrdxlP-dep_Trfase_small.
DR   PANTHER; PTHR13693; CLASS II AMINOTRANSFERASE/8-AMINO-7-OXONONANOATE SYNTHASE; 1.
DR   PANTHER; PTHR13693:SF2; SERINE PALMITOYLTRANSFERASE 1; 1.
DR   Pfam; PF00155; Aminotran_1_2; 1.
DR   SUPFAM; SSF53383; PLP-dependent transferases; 1.
PE   1: Evidence at protein level;
KW   Acyltransferase; Coiled coil; Endoplasmic reticulum; Lipid metabolism;
KW   Membrane; Phosphoprotein; Pyridoxal phosphate; Reference proteome;
KW   Sphingolipid metabolism; Transferase; Transmembrane; Transmembrane helix.
FT   CHAIN           1..473
FT                   /note="Serine palmitoyltransferase 1"
FT                   /id="PRO_0000446338"
FT   TOPO_DOM        1..15
FT                   /note="Lumenal"
FT                   /evidence="ECO:0000255"
FT   TRANSMEM        16..36
FT                   /note="Helical"
FT                   /evidence="ECO:0000255"
FT   TOPO_DOM        37..473
FT                   /note="Cytoplasmic"
FT                   /evidence="ECO:0000255"
FT   REGION          1..66
FT                   /note="Interaction with SPTLC2"
FT                   /evidence="ECO:0000250|UniProtKB:O15269"
FT   MOD_RES         164
FT                   /note="Phosphotyrosine; by ABL"
FT                   /evidence="ECO:0000250|UniProtKB:O15269"
SQ   SEQUENCE   473 AA;  52549 MW;  6AE8F5E60D373B2E CRC64;
     MATVAEQWVL VEMVQALYEA PAYHLILEGI LILWIIRLVF SKTYKLQERS DLTAKEKEEL
     IEEWQPEPLV PPVSRNHPAL NYNIVSGPPT HNIVVNGKEC VNFASFNFLG LLANPRVKAA
     AFASLKKYGV GTCGPRGFYG TFDVHLDLEE RLAKFMKTEE AIIYSYGFST IASAIPAYSK
     RGDIVFVDSA ACFAIQKGLQ ASRSDIKLFK HNDVADLERL LKEQEIEDQK NPRKARVTRR
     FIVAEGLYMN TGTICPLPEL VRLKYKYKAR IFLEESLSFG VLGEHGRGVT EHYGISIDDI
     DLISANMENA LASVGGFCCG RSFVVDHQRL SGQGYCFSAS LPPLLAAAAI EALNIMEENP
     GIFAVLKKKC QTIHKSLQGV SGLKVVGESL CPALHLQLEE STGSRERDMK LLQEIVEQCM
     NKGIALTQAR YLDKEEKCLP PPSIRVVVTV EQTDEELQRA AATIREAAQA VLL
//
